| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| RVNC | Revance Therapeutics, Inc. | Browne L Daniel | CEO and President | Jun 28, 2019 | Option Exercise | $11.02 | 1,000 | 11,024 | 152,193 | Jul 02, 2019, 09:15 PM | |
| RVNC | Revance Therapeutics, Inc. | Browne L Daniel | CEO and President | Mar 18, 2019 | Sale | $15.51 | 11,613 | 180,068 | 151,193 | Mar 19, 2019, 09:01 PM | |
| RVNC | Revance Therapeutics, Inc. | Browne L Daniel | CEO and President | Mar 15, 2019 | Option Exercise | $15.45 | 6,137 | 94,817 | 165,687 | Mar 19, 2019, 09:01 PM | |
| RVNC | Revance Therapeutics, Inc. | Browne L Daniel | CEO and President | Feb 15, 2019 | Option Exercise | $17.69 | 3,154 | 55,794 | 174,389 | Feb 20, 2019, 09:31 PM | |
| RVNC | Revance Therapeutics, Inc. | Browne L Daniel | CEO and President | Feb 19, 2019 | Sale | $17.68 | 5,446 | 96,285 | 168,943 | Feb 20, 2019, 09:31 PM | |
| RVNC | Revance Therapeutics, Inc. | Browne L Daniel | CEO and President | Jun 29, 2018 | Option Exercise | $23.33 | 668 | 15,586 | 142,543 | Jul 03, 2018, 08:17 PM | |
| RVNC | Revance Therapeutics, Inc. | Browne L Daniel | CEO and President | Mar 15, 2018 | Option Exercise | $31.95 | 3,881 | 123,984 | 130,208 | Mar 16, 2018, 08:03 PM | |
| RVNC | Revance Therapeutics, Inc. | Browne L Daniel | CEO and President | Mar 16, 2018 | Option Exercise | $8.74 | 25,452 | 222,348 | 147,327 | Mar 16, 2018, 08:03 PM | |
| RVNC | Revance Therapeutics, Inc. | Browne L Daniel | CEO and President | Mar 07, 2018 | Sale | $31.43 | 27,283 | 857,505 | 131,208 | Mar 09, 2018, 08:36 PM | |
| RVNC | Revance Therapeutics, Inc. | Browne L Daniel | CEO and President | Feb 15, 2018 | Option Exercise | $31.75 | 3,074 | 97,600 | 158,491 | Feb 16, 2018, 07:42 PM | |
| RVNC | Revance Therapeutics, Inc. | Browne L Daniel | CEO and President | Dec 29, 2017 | Option Exercise | $22.99 | 127 | 2,920 | 133,315 | Jan 03, 2018, 08:13 PM | |
| RVNC | Revance Therapeutics, Inc. | Browne L Daniel | CEO and President | Nov 22, 2017 | Sale | $24.94 | 7,600 | 189,570 | 133,188 | Nov 24, 2017, 04:06 PM | |
| RVNC | Revance Therapeutics, Inc. | Browne L Daniel | CEO and President | Oct 18, 2017 | Sale | $26.16 | 7,662 | 200,405 | 140,788 | Oct 20, 2017, 08:10 PM | |
| RVNC | Revance Therapeutics, Inc. | Browne L Daniel | CEO and President | Sep 20, 2017 | Sale | $23.58 | 7,600 | 179,185 | 148,450 | Sep 22, 2017, 08:08 PM | |
| RVNC | Revance Therapeutics, Inc. | Browne L Daniel | CEO and President | Aug 23, 2017 | Sale | $22.48 | 23,131 | 519,875 | 178,850 | Aug 25, 2017, 07:41 PM | |
| RVNC | Revance Therapeutics, Inc. | Browne L Daniel | CEO and President | Jun 30, 2017 | Option Exercise | $18.32 | 1,000 | 18,317 | 178,519 | Jul 05, 2017, 09:29 PM | |
| RVNC | Revance Therapeutics, Inc. | Browne L Daniel | CEO and President | Jun 12, 2017 | Option Exercise | $2.55 | 8,300 | 21,165 | 177,519 | Jun 14, 2017, 08:11 PM | |
| RVNC | Revance Therapeutics, Inc. | Browne L Daniel | CEO and President | May 30, 2017 | Option Exercise | $2.55 | 5,000 | 12,750 | 169,219 | May 31, 2017, 09:38 PM | |
| RVNC | Revance Therapeutics, Inc. | Browne L Daniel | CEO and President | May 22, 2017 | Sale | $20.20 | 12,287 | 248,159 | 183,932 | May 24, 2017, 09:13 PM | |
| RVNC | Revance Therapeutics, Inc. | Browne L Daniel | CEO and President | May 24, 2017 | Sale | $20.35 | 19,713 | 401,091 | 164,219 | May 24, 2017, 09:13 PM | |
| RVNC | Revance Therapeutics, Inc. | Browne L Daniel | CEO and President | Mar 16, 2017 | Option Exercise | $19.20 | 3,171 | 60,885 | 196,219 | Mar 17, 2017, 07:23 PM | |
| RVNC | Revance Therapeutics, Inc. | Browne L Daniel | CEO and President | Feb 22, 2017 | Sale | $20.57 | 11,037 | 227,050 | 200,659 | Feb 24, 2017, 09:04 PM | |
| RVNC | Revance Therapeutics, Inc. | Browne L Daniel | CEO and President | Jan 25, 2017 | Sale | $19.78 | 12,000 | 237,398 | 184,627 | Jan 27, 2017, 08:04 PM | |
| RVNC | Revance Therapeutics, Inc. | Browne L Daniel | CEO and President | Dec 30, 2016 | Option Exercise | $11.58 | 1,000 | 11,577 | 196,627 | Jan 03, 2017, 05:52 PM | |
| RVNC | Revance Therapeutics, Inc. | Browne L Daniel | CEO and President | Dec 28, 2016 | Sale | $20.94 | 12,000 | 251,250 | 195,627 | Dec 30, 2016, 06:38 PM | |
| RVNC | Revance Therapeutics, Inc. | Browne L Daniel | CEO and President | Nov 25, 2016 | Sale | $17.92 | 12,000 | 215,005 | 208,449 | Nov 25, 2016, 09:32 PM | |
| RVNC | Revance Therapeutics, Inc. | Browne L Daniel | CEO and President | Oct 26, 2016 | Sale | $14.85 | 12,000 | 178,199 | 219,627 | Oct 28, 2016, 09:29 PM | |
| RVNC | Revance Therapeutics, Inc. | Browne L Daniel | CEO and President | May 19, 2016 | Option Exercise | $17.11 | 12,050 | 206,176 | 231,627 | May 23, 2016, 09:28 PM | |
| RVNC | Revance Therapeutics, Inc. | Browne L Daniel | CEO and President | Dec 31, 2015 | Option Exercise | $27.00 | 262 | 7,074 | 218,677 | Jan 04, 2016, 09:10 PM | |
| RVNC | Revance Therapeutics, Inc. | Browne L Daniel | CEO and President | Dec 30, 2015 | Option Exercise | $2.55 | 12,045 | 30,715 | 218,415 | Jan 04, 2016, 09:10 PM | |
| RVNC | Revance Therapeutics, Inc. | Browne L Daniel | CEO and President | Jun 30, 2015 | Option Exercise | $14.16 | 1,000 | 14,160 | 1,000 | Jul 02, 2015, 08:35 PM | |
| RVNC | Revance Therapeutics, Inc. | Browne L Daniel | CEO and President | May 19, 2015 | Option Exercise | $25.94 | 12,025 | 311,929 | 205,101 | May 21, 2015, 06:46 PM | |
| RVNC | Revance Therapeutics, Inc. | Browne L Daniel | CEO and President | Nov 28, 2014 | Buy | $16.67 | 6,000 | 100,019 | 172,626 | Dec 01, 2014, 09:26 PM | |
| RVNC | Revance Therapeutics, Inc. | Browne L Daniel | CEO and President | May 19, 2014 | Option Exercise | $32.22 | 96,000 | 3,093,120 | 166,626 | May 21, 2014, 09:30 PM |
Menu